CompletedNot Applicable

Oral Propranolol Versus Fractional Carbon Dioxide CO2 Laser Assisted Delivery of Topical Timolol for Treatment of Infantile Hemangioma

Egypt30 participantsStarted 2025-01-01

Plain-language summary

To assess and compare the efficacy of systemic beta-blocker therapy with the efficacy and safety of fractional carbon dioxide laser-assisted delivery of a topical beta-blocker solution in the treatment of infantile hemangioma.

Who can participate

Age range1 Month – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: , aged 1 month to 12 years \- presenting with superficial, deep, mixed, or proliferating IH. Exclusion Criteria: * other cutaneous or systemic infections * chronic systemic diseases * known allergy to topical timolol maleate * contraindications to laser or beta-blocker therapy * IH involving mucosal or perimucosal sites * and a history of adverse reactions to laser therapy or keloid tendency.

What they're measuring

Improvement of global assessment score of infantile hemangioma

Timeframe: 3 months

Trial details

NCT IDNCT07560332

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-01

View on ClinicalTrials.gov More Infantile Hemangioma (IH) trials